Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influence of Alfacalcidol on Falls in Elderly Postmenopausal Alendronate-Treated Osteopenic/Osteoporotic Women With High Risk of Falls

Next Previous
X
Search
Trial Profile

Influence of Alfacalcidol on Falls in Elderly Postmenopausal Alendronate-Treated Osteopenic/Osteoporotic Women With High Risk of Falls

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Alfacalcidol (Primary) ; Alendronic acid
  • Indications Bone resorption; Postmenopausal osteoporosis
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms ALFA

    • Most Recent Events

    • 11 May 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
    • 09 May 2008 Biomarkers information updated
    • 01 May 2008 The expected completion date for this trial is now May 2008 (Jul 2007 for final data collection date for primary outcome measure) according to ClinicalTrials.gov

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top